On May 25th, photopolymerization 3D printing company Heger Technology announced the completion of a Series C funding round exceeding 300 million yuan. The round was jointly led by Junlian Capital and Dachen, with participation from Gopher Asset Management and Guoke Investment.
This marks the company's first major capital infusion in over six years, following its Series B funding in December 2019.
Heger Technology's story began in 2015. Founder Gui Peiyan, born in 1993 and a former engineering student at the University of Illinois Urbana-Champaign, led a group of six fellow post-90s international students to suspend their studies and return to China in 2015 to establish Heger Technology in Guangzhou. The initial focus was on using 3D printing technology to create custom Bluetooth earphones.
Recognizing the limited market ceiling for consumer-grade earphones, the team quickly identified the issue. In 2018, Heger Technology decided to pivot into the dental field, launching the UltraCraft photopolymerization product line and digital dental solutions.
This path presented higher barriers to entry—dentistry demands stringent requirements for precision, stability, and medical compliance—but also promised greater customer loyalty.
Heger Technology's differentiating strategy lies in full-stack in-house R&D.
The company opted not to take the shortcut of assembling imported components but instead chose to develop its own technology across optical systems, material formulations, hardware equipment, and core algorithms. To date, Heger Technology has invested over 1 billion yuan in cumulative R&D, holding 634 patents, of which 326 are invention patents, accounting for more than half. At the optical level, its self-developed dual-light engine stitching technology achieves automatic calibration accuracy of ±0.02mm.
Financially, Heger Technology's dental strategy is showing early signs of success.
The company disclosed that its dental 3D printing business has achieved scaled profitability, with overseas revenue exceeding 60% of total revenue. It ranks first in market share among North American dental 3D printing companies expanding abroad, and its European market business is growing at a rate exceeding 100%. Domestically, it holds over 60% market share in the dental technician segment, leading the industry.
Consumables are a crucial yet often overlooked component of the company's business model.
Heger Technology develops its full range of materials in-house, covering various high-performance materials such as elastomers and foams. Revenue from the consumables business has risen to approximately 70% of total revenue. This "razor-and-blades" model of "equipment + consumables" contributes significant recurring revenue and partly explains why investors view it as a "technologically scarce asset."
However, high concentration in the dental business is a double-edged sword. Heavy reliance on a single vertical industry means that if the dental market's growth slows or competition intensifies, the company's overall revenue could face substantial volatility risks.
Heger Technology has already begun to address this by expanding into advanced manufacturing fields such as embodied intelligent components and consumer electronics, though the scale of these new directions remains to be seen.
The most significant signal from this funding round is Heger Technology's plan to launch a "true full-color, true 3D consumer-grade/desktop-grade product line" in the third quarter of 2026. Positioned as a new generation of desktop-grade full-color creation tools, it aims to compete with overseas products priced from tens of thousands to hundreds of thousands of yuan.
The path to bringing photopolymerization technology to the consumer market is not straightforward.
Gui Peiyan acknowledged in an interview that photopolymerization involves the handling and management of liquid resin, which is far more challenging than FDM filament. Furthermore, photopolymerization printing itself is a chemical process, making safety and control in consumer-grade settings like homes inherently difficult.
This means that whether desktop-grade full-color products can truly penetrate the market depends not only on technological breakthroughs but also on a series of variables including product pricing, user education costs, and channel development. Currently, the company lacks actual shipment and user feedback data in this area.
Additionally, external competition facing Heger Technology cannot be ignored. The global photopolymerization 3D printing market is still dominated by overseas giants like 3D Systems and Stratasys, while domestic "3D printing four little dragons" have already gained a first-mover advantage in the consumer market.
While Heger Technology has accumulated certain technical depth, it still needs to build its brand awareness and channel coverage.
In terms of market prospects, data from QYResearch shows that the global stereolithography (SLA) printing market size was approximately $887 million in 2024, and is projected to reach $1.597 billion by 2031, representing a compound annual growth rate (CAGR) of about 8.9%.
The potential in the sector exists; the key lies in whether Heger Technology can achieve genuine scaled volume after its consumer-grade products are launched.
Overall, this funding round for Heger Technology reflects continued capital market interest in hard-tech companies with underlying in-house R&D capabilities. The company's profitability in the dental field distinguishes it from many tech firms that "only burn cash without generating returns." However, its transition attempt towards the consumer market remains in its early stages, and its actual effectiveness will depend on market validation following product launch.